Art

J-GLOBAL ID：201902212042507938   Reference number：19A1580070

Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition

日本におけるHelicobacter pylori感染管理のガイドライン:2016年改訂版【JST・京大機械翻訳】

Author (14)： Kato Mototsugu (Department of Gastroenterology, National Hospital Organization Hakodate National Hospital, Hakodate, Hokkaido, Japan) ,  Ota Hiroyoshi (Department of Clinical Laboratory Sciences, Shinshu University School of Medicine, Nagano, Hyogo, Japan) ,  Okuda Masumi (Department of Pediatrics, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan) ,  Kikuchi Shogo (Department of Public Health, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan) ,  Satoh Kiichi (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Tochigi, Japan) ,  Shimoyama Tadashi (Aomori General Health Examination Center, Aomori, Japan) ,  Suzuki Hidekazu (Fellowship Training Center, Medical Education Center, Keio University School of Medicine, Tokyo, Japan) ,  Handa Osamu (Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Furuta Takahisa (Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan) ,  Mabe Katsuhiro (Department of Gastroenterology, National Hospital Organization Hakodate National Hospital, Hakodate, Hokkaido, Japan) ,  Murakami Kazunari (Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan) ,  Sugiyama Toshiro (Department of Cancer Prevention and Therapeutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan) ,  Uemura Naomi (Department of Gastroenterology, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan) ,  Takahashi Shin'ichi (Department of Gastroenterology, Kosei Hospital, Tokyo, Japan)
Material： Helicobacter
Volume： 24  Issue： 4  Page： e12597  Publication year： 2019 
JST Material Number： W2595A  ISSN： 1083-4389  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： BACKGROUND: Since “Helicobacte...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1580070&from=J-GLOBAL&jstjournalNo=W2595A") }}

Thesaurus term： pepsinogen ,  insurance ,  prevention ,  stomach tumor ,  infectious disease ,  microorganism elimination ,  *Helicobacter pylori ,  puberty(human) ,  human(primates) ,  *Helicobacter ,  therapy ,  gastritis ,  serum ,  alcohol ,  nitrogen heterocyclic compound ,  nitro compound ,  amino sugar ,  ether ,  macrocyclic compound ,  lactone ,  glycoside(except carbohydrate) ,  deoxysugar ,  pyranoside ,  sugar ether ,  diol ,  tertiary amine ,  hydroxy ketone ,  amino acid ,  lactam ,  phenolic compound ,  sulfur heterocyclic compound ,  primary amine

Author keywords (5)： diagnosis ,  gastric cancer prevention ,  guidelines ,  indication ,  treatment

JST classification (3)： Infectious diseases,parasitics diseases in general.  (GD01010H) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Treatment for infectious diseases,parasitic diseases.  (GD01030D)

Substance index (3)： Metronidazole ,  Clarithromycin ,  Amoxicillin

Terms in the title (5)： 日本 ,  Helicobacter ,  感染管理 ,  ガイドライン ,  改訂